Publications
By Year
Now showing items 101-120 of 5325 records
Long-term mortality outcome of a primary care-based mobile health intervention for stroke management: Six-year follow-up of a cluster-randomized controlled trial.
Xingxing Chen; Enying Gong; Jie Tan; Elizabeth L Turner; John A Gallis; Shifeng Sun; Siran Luo; Fei Wu; Bolu Yang; Yutong Long; Yilong Wang; Zixiao Li; Yun Zhou; Shenglan Tang; Janet P Bettger; Brian Oldenburg; Xiaochen Zhang; Jianfeng Gao; Brian S Mittman; Valery L Feigin; Ruitai Shao; Shah Ebrahim; Lijing L Yan
PLOS MEDICINE - 01 Mar 2025
Despite growing evidence of primary care-based interventions for chronic disease management in resource-limited settings, long-term post-trial effects remain inconclusive. We investigated the association of a 12-month system-integrated technology-enabled model of care (SINEMA) intervention with mortality outcomes among patients experiencing stroke at 6-year post-trial. This study (clinicltiral....
Baseline and 10-year change in the number of ideal cardiovascular health metrics and sudden cardiac death in the community.
Jean-Philippe Empana; Marie-Cecile Perier; Peder Emile Warming; Eloi Marijon; Irene van Valkengoed; Frederik N Ågesen; Eva Prescott; Rezza Jabbari; Rachel E Climie; Petra Elders; Marieke T Blom; Peter J Schwartz; Hanno L Tan; J Tfelt-Hansen; Xavier Jouven
EUROPACE : EUROPEAN PACING, ARRHYTHMIAS, AND CARDIAC ELECTROPHYSIOLOGY : JOURNAL OF THE WORKING GROUPS ON CARDIAC PACING, ARRHYTHMIAS, AND CARDIAC CELLULAR ELECTROPHYSIOLOGY OF THE EUROPEAN SOCIETY OF CARDIOLOGY - 28 Mar 2025
Adherence to an ideal cardiovascular health (CVH) might contribute to lower the burden of sudden cardiac death (SCD) in the community. We aimed to examine the association between the number of ideal CVH metrics at baseline and of its change over 10 years with the risk of SCD. The Copenhagen City Heart Study is a community-based prospective cohort study. The number of ideal CVH metrics (range 0-...
Beyond platelet activation: dysregulated lipid metabolism in defining risk and pathophysiology of VITT.
Hannah Stevens; James D McFadyen; Natalie A Mellett; David J Lynn; Thy Duong; Corey Giles; Jane James; Rochelle Botten; Georgina Eden; Miriam Lynn; Paul Monagle; Peter J Meikle; Sanjeev Chunilal; Karlheinz Peter; Huyen Tran
RESEARCH AND PRACTICE IN THROMBOSIS AND HAEMOSTASIS - 01 Jan 2025
VITT has emerged as a rare but serious adverse event linked primarily to adenoviral vector COVID-19 vaccinations, such as ChAdOx1-S (Oxford/AstraZeneca) vaccination. The syndrome is characterized by thrombosis with thrombocytopenia, elevated D-dimer, and pathologic platelet factor 4 antibodies within 42 days of vaccination. Despite dysregulated lipid metabolism underpinning many thrombotic cond...
Mitochondrial damage in muscle specific PolG mutant mice activates the integrated stress response and disrupts the mitochondrial folate cycle.
Simon T Bond; Emily J King; Shannen M Walker; Christine Yang; Yingying Liu; Kevin H Liu; Aowen Zhuang; Aaron W Jurrjens; Haoyun A Fang; Luke E Formosa; Artika P Nath; Sergio Ruiz Carmona; Michael Inouye; Thy Duong; Kevin Huynh; Peter J Meikle; Simon Crawford; Georg Ramm; Sheik Nadeem Elahee Doomun; David P de Souza; Danielle L Rudler; Anna C Calkin; Aleksandra Filipovska; David W Greening; Darren C Henstridge; Brian G Drew
NATURE COMMUNICATIONS - 08 Mar 2025
During mitochondrial damage, information is relayed between the mitochondria and nucleus to coordinate precise responses to preserve cellular health. One such pathway is the mitochondrial integrated stress response (mtISR), which is known to be activated by mitochondrial DNA (mtDNA) damage. However, the causal molecular signals responsible for activation of the mtISR remain mostly unknown. A ge...
Burden of disease scenarios by state in the USA, 2022-50: a forecasting analysis for the Global Burden of Disease Study 2021.
Art Schuermans
LANCET (LONDON, ENGLAND) - 07 Dec 2024
The capacity to anticipate future health issues is important for both policy makers and practitioners in the USA, as such insights can facilitate effective planning, investment, and implementation strategies. Forecasting trends in disease and injury burden is not only crucial for policy makers but also garners substantial interest from the general populace and leads to a better-informed public....
Special Issue: "New Trends in Diabetes, Hypertension, and Cardiovascular Diseases-2nd Edition".
Yutang Wang; Dianna J Magliano
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES - 07 Jan 2025
Cardiovascular diseases (CVDs) encompass a range of conditions affecting both the heart (e.g., coronary heart disease and heart failure [1]) and blood vessels (e.g., cerebrovascular disease [2] and peripheral artery disease [3]) [...].
The Youth Fitness International Test (YFIT) battery for monitoring and surveillance among children and adolescents: A modified Delphi consensus project with 169 experts from 50 countries and territories.
Francisco B Ortega; Kai Zhang; Cristina Cadenas-Sanchez; Mark S Tremblay; Gregor Jurak; Grant R Tomkinson; Jonatan R Ruiz; Katja Keller; Christine Delisle Nyström; Jennifer M Sacheck; Russell Pate; Kathryn L Weston; Tetsuhiro Kidokoro; Eric T Poon; Lucy-Joy M Wachira; Ronald Ssenyonga; Thayse Natacha Q F Gomes; Carlos Cristi-Montero; Brooklyn J Fraser; Claudia Niessner; Vincent O Onywera; Yang Liu; Li-Lin Liang; Stephanie A Prince; David R Lubans; Justin J Lang;
JOURNAL OF SPORT AND HEALTH SCIENCE - 20 Nov 2024
Physical fitness in childhood and adolescence is associated with a variety of health outcomes and is a powerful marker of current and future health. However, inconsistencies in tests and protocols limit international monitoring and surveillance. The objective of the study was to seek international consensus on a proposed, evidence-informed, Youth Fitness International Test (YFIT) battery and pr...
An In Silico Investigation of the Pathogenic G151R G Protein-Gated Inwardly Rectifying K<sup>+</sup> Channel 4 Variant to Identify Small Molecule Modulators.
Eleni Pitsillou; Julia J Liang; Noa Kino; Jessica L Lockwood; Andrew Hung; Assam El-Osta; Asmaa S AbuMaziad; Tom C Karagiannis
BIOLOGY - 29 Nov 2024
Primary aldosteronism is characterised by the excessive production of aldosterone, which is a key regulator of salt metabolism, and is the most common cause of secondary hypertension. Studies have investigated the association between primary aldosteronism and genetic alterations, with pathogenic mutations being identified. This includes a glycine-to-arginine substitution at position 151 (G151R)...
Improving the Sustainability of Public Health Interventions: The INNOVATE Model
Abha Shrestha; Dominika Kwasnicka; Tilahun Haregu; Chris Lynch; Pilvikki Absetz; J Jaime Miranda; Kavumpurathu R Thankappan; Brian Oldenburg
GLOBAL IMPLEMENTATION RESEARCH AND APPLICATIONS - 07 Feb 2025
Introduction Improving the sustainability of public health interventions is a priority for policymakers and program implementers. However, existing theories, models, and frameworks focus on describing constructs, processes, and measures of sustainability. Models to guide the improvement of sustainability of public health interventions are currently lacking. Objective To develop an evidence-bas...
An optimized plasmalogen modulating dietary supplement provides greater protection in a male than female mouse model of dilated cardiomyopathy.
Teleah G Belkin; Emma I Masterman; Gunes S Yildiz; Helen Kiriazis; Natalie A Mellett; Jonathon Cross; Kyah Grigolon; Akshima Dogra; Daniel Donner; Roger Chooi; Amy Liang; Andrew R Kompa; Junichi Sadoshima; Amanda J Edgley; David W Greening; Peter J Meikle; Yow Keat Tham; Julie R McMullen
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY PLUS - 01 Mar 2025
We previously reported that plasmalogens, a class of phospholipids, were decreased in a setting of dilated cardiomyopathy (DCM). Plasmalogen levels can be modulated via a dietary supplement called alkylglycerols (AG) which has demonstrated benefits in some disease settings. However, its therapeutic potential in DCM remained unknown. To determine whether an optimized AG supplement could restore ...
Reduced PI3K(p110α) induces atrial myopathy, and PI3K-related lipids are dysregulated in athletes with atrial fibrillation.
Sebastian Bass-Stringer; Jieting Luo; Natalie A Mellett; Jenny Y Y Ooi; Aascha A D'Elia; Daniel G Donner; Martin Ezeani; Roger Chooi; Yow Keat Tham; Celeste M K Tai; Claudia A Harmawan; Helen Kiriazis; Aya Matsumoto; Gunes S Yildiz; Bianca C Bernardo; Lauren Bottrell; Emma I Masterman; Gavriel Olshansky; Erin J Howden; Jonathon H Cross; Christoph E Hagemeyer; Ruby C Y Lin; Colleen J Thomas; Graham W Magor; Andrew C Perkins; Thomas H Marwick; Hiroshi Kawakami; Peter J Meikle; David W Greening; Kate L Weeks; André La Gerche; Kristel Janssens; Julie R McMullen
JOURNAL OF SPORT AND HEALTH SCIENCE - 16 Jan 2025
Elucidating mechanisms underlying atrial myopathy, which predisposes individuals to atrial fibrillation (AF), will be critical for preventing/treating AF. In a serendipitous discovery, we identified atrial enlargement, fibrosis, and thrombi in mice with reduced phosphoinositide 3-kinase (PI3K) in cardiomyocytes. PI3K(p110α) is elevated in the heart with exercise and is critical for exercise-ind...
Targeting EZH1/2: tackling epigenetic resistance advances cancer therapy.
Assam El-Osta; Ram Abou Zaki
MEDCOMM - 01 Jan 2025
In a recent paper published in Nature, the mechanisms of action and resistance in histone lysine methylation-targeted treatment of adult T-cell leukemia/lymphoma (ATL) were characterised.1 The study showed tumor regression begins as early as the first week of valemetostat treatment with patients enrolled in Phase I and II trials achieving complete remission. This is mediated by reducing histone...
Branched silver-iron oxide nanoparticles enabling highly effective targeted and localised drug-free thrombolysis.
Karla X Vazquez-Prada; Shehzahdi S Moonshi; Yuao Wu; Karlheinz Peter; Xiaowei Wang; Zhi Ping Xu; Hang Thu Ta
BIOMATERIALS SCIENCE - 17 Feb 2025
Ultrasound has been widely used as an external stimulus to trigger drug release from nanomaterials in thrombosis treatment. Here, we introduce a novel strategy leveraging nanomaterials not for drug delivery, but for enhancing US-induced thrombolysis. This innovative strategy is particularly significant, as thrombolytic drugs inherently pose a risk of systemic bleeding. We combined branched silv...
Acetylcholine-loaded nanoparticles protect against doxorubicin-induced toxicity in<i>in vitro</i>cardiac spheroids.
Clara Liu Chung Ming; Runali Patil; Ahmed Refaat; Sean Lal; Xiaowei Wang; Carmine Gentile
BIOFABRICATION - 18 Feb 2025
Doxorubicin (DOX) is widely used in chemotherapy, yet it significantly contributes to heart failure-associated death. Acetylcholine (ACh) is cardioprotective by enhancing heart rate variability and reducing mitochondrial dysfunction and inflammation. Nonetheless, the protective role of ACh in countering DOX-induced cardiotoxicity (DIC) remains underexplored as current approaches to increasing A...
Age at type 1 diabetes onset does not influence attained brain volume.
Tor-Björn Claesson; Stefan Mutter; Jukka Putaala; Eero Salli; Daniel Gordin; Per-Henrik Groop; Juha Martola; Lena M Thorn
BMC ENDOCRINE DISORDERS - 18 Feb 2025
Type 1 diabetes is suspected to hamper brain growth, implying that people with earlier diabetes onset would, on average, achieve lower maximal brain volume. We set out to test this hypothesis. Examining brain MRI scans of middle-aged people with type 1 diabetes, we related age at diabetes onset to intracranial volume in 180 participants, as well as to cerebral gray and white matter volumes in a...
Sex-Specific Association of Myocardial Fibrosis With Mortality in Patients With Aortic Stenosis.
Soongu Kwak; Anvesha Singh; Russell J Everett; Thomas A Treibel; Jaehyun Lim; Sungho Won; Michelle C Williams; Krithika Loganathan; Rong Bing; Neil Craig; Trisha Singh; Shruti Joshi; Heesun Lee; Whal Lee; Yong-Jin Kim; Calvin W L Chin; Miho Fukui; Tarique Al Musa; Marzia Rigolli; Lionel Tastet; Laura E Dobson; Stephanie Wiesemann; Vanessa M Ferreira; Gabriella Captur; Sahmin Lee; Jeanette Schulz-Menger; Erik B Schelbert; Marie-Annick Clavel; Sung-Ji Park; Costanza Pellegrini; Martin Hadamitzky; Bernhard L Gerber; David E Newby; Saul G Myerson; Phillipe Pibarot; João L Cavalcante; Gerry P McCann; John P Greenwood; James C Moon; Marc R Dweck; Seung-Pyo Lee
JAMA CARDIOLOGY - 19 Feb 2025
Myocardial fibrosis in aortic stenosis (AS) may exhibit sex differences. However, its prognostic significance in women with AS remains unclear. To investigate sex differences in myocardial fibrosis assessed by cardiovascular magnetic resonance (CMR) and evaluate its prognostic value in women and men with AS. Patients with severe AS who underwent CMR before aortic valve replacement (AVR) were pr...
Mechanisms of ligand-mediated modulation of mineralocorticoid receptor signaling.
Peter J Fuller; Jun Yang; Morag J Young; Timothy J Cole
MOLECULAR AND CELLULAR ENDOCRINOLOGY - 19 Feb 2025
The mineralocorticoid receptor plays a central role in homeostasis, mediating the regulation by aldosterone of epithelial sodium transport. In addition, it regulates a range of responses in other tissues where it is likely responding to both mineralocorticoids and glucocorticoids. Structural, functional and evolutionary studies have provided insights into the mechanisms of receptor activation b...
Show more...